A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Pfizer
Pfizer
Lomond Therapeutics Holdings, Inc.
Kura Oncology, Inc.
Celgene
Ipsen
Hutchmed
Hutchmed
Bayer
Jonsson Comprehensive Cancer Center
Takeda
Fred Hutchinson Cancer Center